AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32649760 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided 3 × 10-g doses of LNS
Number of subjects: 26
Study 32649760 — intervention group
Group type: COMPARATOR
Intervention: Control (no LNS)
Number of subjects: 26
Study 33248154 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants instructed about the precise CS‐US contingency before conditioning
Number of subjects: 102
Study 33248154 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants instructed to discover the CS‐US contingency
Number of subjects: 102
Study 33248154 — intervention group
Group type: COMPARATOR
Intervention: No contingency instructions provided (Control group)
Number of subjects: 102
Study 33248154 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency reversal instructions
Number of subjects: 102
Study 36112256 — intervention group
Group type: EXPERIMENTAL
Intervention: LipiFlow® thermal pulsation treatment
Number of subjects: 50
Study 36112256 — intervention group
Group type: COMPARATOR
Intervention: Warm compress combined with manual lid massage
Number of subjects: 50
Study 34649555 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min mindful breathing session
Number of subjects: 80
Study 34649555 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 34882106 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-guided care (SedLine)
Number of subjects: 1560
Study 34882106 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1560
Study 33249611 — intervention group
Group type: EXPERIMENTAL
Intervention: Paula Method exercises
Number of subjects: 64
Study 33249611 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study 33233658 — intervention group
Group type: EXPERIMENTAL
Intervention: Partly fermented infant formula (IF) with postbiotics, 2'‐FL, scGOS/lcFOS, and milk fat
Number of subjects: 215
Study 33233658 — intervention group
Group type: COMPARATOR
Intervention: Control group (IF with 0.8 g/100 mL scGOS/lcFOS (9:1))
Number of subjects: 215
Study 35347362 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for acute thrombi
Number of subjects: 56
Study 35347362 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for subacute thrombi
Number of subjects: 56
Study 35347362 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis (CDT) for old thrombi
Number of subjects: 56
Study 34987350 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial occupational therapy combined with anodal tDCS (12 sessions, 20 minutes, 2 mA intensity on the left DLPFC)
Number of subjects: 24
Study 34987350 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 35339987 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine (1.66 g, twice a day for 3 weeks)
Number of subjects: 110
Study 35339987 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical aspect, no L-arginine, twice a day for 3 weeks)
Number of subjects: 110
Study 32641240 — intervention group
Group type: EXPERIMENTAL
Intervention: ADXS-HPV (1 × 10^9 colony-forming units in 250 mL IV over 15 min every 28 days)
Number of subjects: 50
Study 32641240 — intervention group
Group type: EXPERIMENTAL
Intervention: ADXS-HPV
Number of subjects: 50
Study 34971264 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based music programme plus standard care (SC)
Number of subjects: 130
Study 34971264 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based reading programme plus standard care (SC)
Number of subjects: 130
Study 34971264 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 130
Study 34971264 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based music programme plus SC
Number of subjects: 130
Study 34971264 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based reading programme plus SC
Number of subjects: 130
Study 32099001 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Networks (CNNs) trained on CT imaging
Number of subjects: 549
Study 32099001 — intervention group
Group type: COMPARATOR
Intervention: Experienced radiologists' assessments
Number of subjects: 549
Study 35137394 — intervention group
Group type: COMPARATOR
Intervention: erenumab 70 mg
Number of subjects: 1532
Study 35137394 — intervention group
Group type: COMPARATOR
Intervention: erenumab 140 mg
Number of subjects: 1532
Study 34856179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained provision of multiple self-tests to women at high risk of HIV infection.
Number of subjects: 2090
Study 34856179 — intervention group
Group type: COMPARATOR
Intervention: Referral cards for facility-based testing (comparison group).
Number of subjects: 2090
Study 35813628 — intervention group
Group type: COMPARATOR
Intervention: VED
Number of subjects: 105
Study 35813628 — intervention group
Group type: COMPARATOR
Intervention: Li-ESWT
Number of subjects: 105
Study 35813628 — intervention group
Group type: EXPERIMENTAL
Intervention: VED plus Li-ESWT
Number of subjects: 105
Study 34106758 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 0
Study 34106758 — intervention group
Group type: EXPERIMENTAL
Intervention: IV thrombolytic treatment
Number of subjects: 0
Study 34106758 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodality imaging
Number of subjects: 0
Study 34106758 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced neuroimaging
Number of subjects: 0
Study 34106758 — intervention group
Group type: EXPERIMENTAL
Intervention: CT, CTA, MRI, MRA
Number of subjects: 0
Study 32522031 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine facility
Number of subjects: 3000
Study 32522031 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 3000
Study 32522031 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic control (HbA1c)
Number of subjects: 3000
Study 34871782 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based daily feedback and counseling platform (App group)
Number of subjects: 197
Study 34871782 — intervention group
Group type: COMPARATOR
Intervention: Routine lactation counseling and support (control group)
Number of subjects: 197
Study 32195159 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal massage with Ostrich oil
Number of subjects: 77
Study 32195159 — intervention group
Group type: COMPARATOR
Intervention: Control group (no perineal massage with Ostrich oil)
Number of subjects: 77
Study 36052975 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-derived 3D virtual explanation module accessed via smartphone before admission.
Number of subjects: 62
Study 36052975 — intervention group
Group type: EXPERIMENTAL
Intervention: Link recipients (third parties) of the intervention group.
Number of subjects: 62
Study 36052975 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 62
Study 33908425 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block (NB) with ropivacaine through an NB catheter and a sham saline periarticular injection (PI).
Number of subjects: 74
Study 33908425 — intervention group
Group type: COMPARATOR
Intervention: Periarticular injection (PI) of ropivacaine, morphine, ketorolac, and epinephrine, with a sham saline infusion via an NB catheter.
Number of subjects: 74
Study 35672834 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 511
Study 35672834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study 35672834 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 511
Study 32611445 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-lapse imaging (TLI)
Number of subjects: 1575
Study 32611445 — intervention group
Group type: EXPERIMENTAL
Intervention: Undisturbed culture
Number of subjects: 1575
Study 32611445 — intervention group
Group type: COMPARATOR
Intervention: Current standard methods of embryo incubation and assessment
Number of subjects: 1575
Study 35657971 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental control strategies (ECS) plus asthma controller medication titration
Number of subjects: 155
Study 35657971 — intervention group
Group type: COMPARATOR
Intervention: Controller medication titration alone
Number of subjects: 155
Study 33427618 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase (8 mg every 2 weeks or monthly)
Number of subjects: 0
Study 33427618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33427618 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegloticase (monthly)
Number of subjects: 0
Study 33231929 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin (titrated doses of 2.5, 5, 7.5, or 10 mg/day)
Number of subjects: 194
Study 33231929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 34718252 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS two sessions per week
Number of subjects: 91
Study 34718252 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS five sessions per week
Number of subjects: 91
Study 34718252 — intervention group
Group type: COMPARATOR
Intervention: sham rTMS two sessions per week
Number of subjects: 91
Study 34718252 — intervention group
Group type: COMPARATOR
Intervention: sham rTMS five sessions per week
Number of subjects: 91
Study 32065831 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 10 μg of IFN‐β‐1a once daily for 6 days
Number of subjects: 301
Study 32065831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 32065831 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 10 μg of IFN‐β‐1a
Number of subjects: 301
Study 36180115 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a prescription dose of 30‐50 Gy in 3‐5 fractions
Number of subjects: 0
Study 36180115 — intervention group
Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) only
Number of subjects: 0
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask wearing (any type)
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloth facemasks
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 facemasks
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical facemasks
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Good knowledge about COVID-19
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitude towards precautions
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in facemask effectiveness
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Discomfort wearing a facemask
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Government pressure to wear facemask
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital status
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of the disease
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in the effectiveness of a facemask
Number of subjects: 417
Study 33711038 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling government pressure
Number of subjects: 417
Study 36283843 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (10-minute phone-based psychoeducation plus feedback session)
Number of subjects: 51
Study 36283843 — intervention group
Group type: EXPERIMENTAL
Intervention: Health coaching (two 45-minute sessions including education, feedback, motivational interviewing, and goal setting)
Number of subjects: 51
Study 32423512 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasotraline 6 mg/d
Number of subjects: 485
Study 32423512 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasotraline 4 mg/d
Number of subjects: 485
Study 32423512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 485
Study 32808234 — intervention group
Group type: EXPERIMENTAL
Intervention: Dejian mind‐body intervention (DMBI)
Number of subjects: 75
Study 32808234 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 75
Study 32808234 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 35411554 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy and FIT
Number of subjects: 140000
Study 33433246 — intervention group
Group type: EXPERIMENTAL
Intervention: Integra with NPWT
Number of subjects: 36
Study 33433246 — intervention group
Group type: COMPARATOR
Intervention: Integra with partial packing compression dressings (control)
Number of subjects: 36
Study 36226541 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS) paired with rehabilitation
Number of subjects: 0
Study 36226541 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation paired with rehabilitation (Control)
Number of subjects: 0
Study 33025749 — intervention group
Group type: EXPERIMENTAL
Intervention: Moses 2.0
Number of subjects: 27
Study 33025749 — intervention group
Group type: COMPARATOR
Intervention: non-Moses
Number of subjects: 27
Study 33243587 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended depth-of-focus (EDOF) contact lens
Number of subjects: 30
Study 33243587 — intervention group
Group type: COMPARATOR
Intervention: Conventional multifocal (Biofinity MF) contact lens
Number of subjects: 30
Study 32100275 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined-ABT (linzagolix 200 mg/ABT for 10 weeks)
Number of subjects: 32
Study 32100275 — intervention group
Group type: COMPARATOR
Intervention: Delayed-ABT (linzagolix 200 mg for 4 weeks followed by linzagolix 200 mg/ABT for 6 weeks)
Number of subjects: 32
Study 32100275 — intervention group
Group type: COMPARATOR
Intervention: Linzagolix alone
Number of subjects: 32
Study 35616653 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit formation treatment delivered face to face during 12 weekly home‐based sessions (45 min each)
Number of subjects: 30
Study 35616653 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 30
Study 35616653 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit formation (mechanism of change) assessed in treatment group only
Number of subjects: 30
Study 33508159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm Q-switched Nd:YAG laser treatment
Number of subjects: 19
Study 33508159 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 19
Study 32912977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR) training, task-based training to downregulate negative affect, 4 sessions over 2 weeks.
Number of subjects: 0
Study 32912977 — intervention group
Group type: COMPARATOR
Intervention: Control training, picture viewing, 4 sessions over 2 weeks.
Number of subjects: 0
Study 32912977 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR) training
Number of subjects: 0
Study 34130581 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion
Number of subjects: 0
Study 33844890 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 4 mg
Number of subjects: 100
Study 33844890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35714174 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg iv morphine
Number of subjects: 29
Study 35714174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 29
Study 34270615 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective training on patient-centred communication
Number of subjects: 1120
Study 34270615 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 1120
Study 33832885 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesecure
Number of subjects: 0
Study 33832885 — intervention group
Group type: COMPARATOR
Intervention: Plasicure
Number of subjects: 0
Study 36209091 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocin (15 mg/day) for 90 days
Number of subjects: 40
Study 36209091 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 40
Study 32443963 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming (EG)
Number of subjects: 66
Study 32443963 — intervention group
Group type: COMPARATOR
Intervention: Traditional multicomponent training (MG)
Number of subjects: 66
Study 35927637 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU per day for six weeks)
Number of subjects: 22
Study 35927637 — intervention group
Group type: COMPARATOR
Intervention: Control group (lactose placebo)
Number of subjects: 22
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC adjuvanted with GLA-SE (100 μg dose)
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC adjuvanted with Alhydrogel (100 μg dose)
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC/Alhydrogel
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC/GLA-SE
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC (100 μg dose and GLA-SE)
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC (100 μg dose)
Number of subjects: 68
Study 32032566 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIMVAC (Alhydrogel or GLA-SE)
Number of subjects: 68
Study 34384273 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary collaborative nursing intervention (MCNI)
Number of subjects: 84
Study 34384273 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing procedure (Control)
Number of subjects: 84
Study 32141373 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home iPad lessons (8 weekly sessions)
Number of subjects: 83
Study 32141373 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 83
Study 35347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized pragmatic randomized controlled trial (RCT)
Number of subjects: 0
Study 35347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster RCT
Number of subjects: 0
Study 35347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-case RCT
Number of subjects: 0
Study 35347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Single arm RCT with objective performance criteria
Number of subjects: 0
Study 35347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially nested RCT
Number of subjects: 0
Study 34527611 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg intravenous zoledronic acid
Number of subjects: 70
Study 34527611 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg intravenous zoledronic acid
Number of subjects: 70
Study 34527611 — intervention group
Group type: COMPARATOR
Intervention: 2 mg and 4 mg intravenous zoledronic acid
Number of subjects: 70
Study 36446685 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Seldinger method (n=55)
Number of subjects: 111
Study 36446685 — intervention group
Group type: COMPARATOR
Intervention: Open surgical cutdown method (n=56)
Number of subjects: 111
Study 33524545 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant ADT for 6 months starting 4 months before prostate radiotherapy
Number of subjects: 393
Study 33524545 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant ADT for 6 months starting simultaneously with prostate radiotherapy
Number of subjects: 393
Study 35652877 — intervention group
Group type: EXPERIMENTAL
Intervention: PENG group
Number of subjects: 39
Study 35652877 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 32145276 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest tertile of serum omentin-1
Number of subjects: 303
Study 32145276 — intervention group
Group type: COMPARATOR
Intervention: Lowest tertile of serum omentin-1
Number of subjects: 303
Study 32145276 — intervention group
Group type: COMPARATOR
Intervention: Middle tertile of serum omentin-1
Number of subjects: 303
Study 35998351 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers assessing students of lower SES
Number of subjects: 416
Study 35998351 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers who believed schooling is meritocratic
Number of subjects: 416
Study 35998351 — intervention group
Group type: COMPARATOR
Intervention: Teachers assessing students of different ethnic backgrounds (White British vs. Black Caribbean)
Number of subjects: 416
Study 34919247 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 400 mg twice a day
Number of subjects: 102
Study 34919247 — intervention group
Group type: COMPARATOR
Intervention: Ursodeoxycholic Acid 250 mg twice a day
Number of subjects: 102
Study 34919247 — intervention group
Group type: COMPARATOR
Intervention: Pentoxifylline 400 mg twice a day
Number of subjects: 102
Study 35505312 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 24
Study 32532175 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-enhanced behavioral parent training (BPT)
Number of subjects: 63
Study 32532175 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral parent training (BPT)
Number of subjects: 63
Study 35421679 — intervention group
Group type: EXPERIMENTAL
Intervention: Paramedian approach for ultrasound-assisted spinal anesthesia
Number of subjects: 112
Study 35421679 — intervention group
Group type: COMPARATOR
Intervention: Midline approach for ultrasound-assisted spinal anesthesia
Number of subjects: 112
Study 33838673 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg
Number of subjects: 0
Study 33838673 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorogenic acid plus caffeine 200 mg each
Number of subjects: 0
Study 33838673 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 0
Study 32110819 — intervention group
Group type: EXPERIMENTAL
Intervention: Al/Mg hydroxide antacid
Number of subjects: 24
Study 32110819 — intervention group
Group type: EXPERIMENTAL
Intervention: Food
Number of subjects: 24